SEP-363856 for Treatment of Schizophrenia - MD Magazine

Submitted by Anonymous (not verified) on Sun, 05/26/2019 - 11:00

SEP-363856 for Treatment of Schizophrenia  MD MagazineInvestigators presented the results of a 4-week trial examining the efficacy of SEP-363856 at APA 2019 in San Francisco, CA.